Check out the companies making headlines before the market opens. Nvidia — Shares fell 2%, extending losses from Thursday, when Nvidia closed down 3.5%. The maker of artificial intelligence chips briefly surpassed Microsoft to become the most valuable public company on Tuesday before its shares fell. Sarepta Therapeutics — Shares of the biopharma surged 37% after the U.S. Food and Drug Administration approved expanded use of Sarepta’s Elevidys gene therapy, which will treat patients with Duchenne muscular dystrophy. Traditionally, the therapy has been approved for all patients age 4 or older who are able to walk, with accelerated approval for those who are unable to walk. Nike — Shares of the sportswear maker rose 1% after Oppenheimer upgraded the stock to outperform. The company also restored Nike as a top pick and said the stock is expected to rebound gradually as the company refocuses on product innovation and brand building. Asana — Shares of Asana rose more than 3% after the software company announced a $150 million stock buyback plan. The company expects its stock repurchase program to continue until June 30, 2025. On Thursday, Gilead announced the success of an AIDS prevention vaccine in late-stage trials. LendingTree — Shares in the online lending market fell slightly after Bloomberg reported that hackers were auctioning off data stolen from the site. LendingTree was the victim of a cyberattack against cloud computing company Snowflake. APPLE — Shares of the iPhone maker rose as Bernstein Co. raised prices. Analyst Toni Sacconaghi asserted that the more optimistic outlook is related to his view that Apple can be a leader in the artificial intelligence boom “not a laggard.” Delta Air Lines — Shares of Delta Air Lines rose 0.7% on Thursday after news that the airline announced a quarterly dividend of 15 cents per share, a 50% increase from its previous share. —CNBC’s Brian Evans, Michelle Fox, Jesse Pound and Sarah Min contributed reporting.
